$0.69 EPS Expected for Dolby Laboratories, Inc. (DLB) This Quarter

Wall Street analysts expect that Dolby Laboratories, Inc. (NYSE:DLB) will announce earnings of $0.69 per share for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Dolby Laboratories’ earnings. The lowest EPS estimate is $0.68 and the highest is $0.70. Dolby Laboratories posted earnings per share of $0.79 during the same quarter last year, which would indicate a negative year over year growth rate of 12.7%. The business is scheduled to report its next earnings results on Wednesday, January 23rd.

According to Zacks, analysts expect that Dolby Laboratories will report full-year earnings of $3.07 per share for the current financial year, with EPS estimates ranging from $2.99 to $3.14. For the next financial year, analysts expect that the firm will post earnings of $3.44 per share, with EPS estimates ranging from $3.43 to $3.45. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Dolby Laboratories.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Wednesday, October 24th. The electronics maker reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.17. Dolby Laboratories had a net margin of 10.43% and a return on equity of 12.72%. The business had revenue of $265.33 million for the quarter, compared to analyst estimates of $272.42 million. During the same period in the previous year, the business posted $0.21 earnings per share.

A number of brokerages have recently issued reports on DLB. B. Riley boosted their price target on shares of Dolby Laboratories from $61.00 to $69.00 and gave the stock a “neutral” rating in a research note on Thursday, July 26th. Barrington Research reiterated a “buy” rating and set a $78.00 price target on shares of Dolby Laboratories in a research note on Thursday, July 26th. Tigress Financial reiterated a “buy” rating on shares of Dolby Laboratories in a research note on Friday, September 7th. R. F. Lafferty began coverage on shares of Dolby Laboratories in a research note on Wednesday, September 5th. They set a “buy” rating and a $81.00 price target on the stock. Finally, Zacks Investment Research reiterated a “sell” rating on shares of Dolby Laboratories in a research note on Tuesday, November 13th. One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $72.80.

In other Dolby Laboratories news, CFO Lewis Chew sold 35,000 shares of the company’s stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $69.44, for a total transaction of $2,430,400.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Peter C. Gotcher sold 3,334 shares of the company’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $70.00, for a total transaction of $233,380.00. The disclosure for this sale can be found here. Insiders have sold 60,976 shares of company stock worth $4,250,305 over the last 90 days. 43.80% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Rehmann Capital Advisory Group grew its position in Dolby Laboratories by 7,948.4% during the third quarter. Rehmann Capital Advisory Group now owns 12,314 shares of the electronics maker’s stock worth $176,000 after buying an additional 12,161 shares during the period. Commonwealth Bank of Australia acquired a new position in Dolby Laboratories during the third quarter worth about $209,000. Oakbrook Investments LLC acquired a new position in Dolby Laboratories during the third quarter worth about $211,000. Tower Research Capital LLC TRC acquired a new position in Dolby Laboratories during the third quarter worth about $213,000. Finally, Summit Creek Advisors LLC acquired a new position in Dolby Laboratories during the third quarter worth about $227,000. Institutional investors own 57.38% of the company’s stock.

Shares of Dolby Laboratories stock opened at $67.54 on Friday. Dolby Laboratories has a 52-week low of $58.37 and a 52-week high of $74.29. The stock has a market cap of $7.00 billion, a PE ratio of 28.14, a PEG ratio of 2.30 and a beta of 0.73.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 14th. Shareholders of record on Monday, November 5th were given a dividend of $0.19 per share. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.16. This represents a $0.76 annualized dividend and a yield of 1.13%. The ex-dividend date was Friday, November 2nd. Dolby Laboratories’s dividend payout ratio is presently 31.67%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Featured Article: Dividend Aristocrat Index

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply